chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4/29/2022-Presents to ED via EMS d/t AMS. HX of seizures,  not currently on any seizure meds. Covid +.  Ct head: no acute intracranial abnormality.  CXR- no acute cardiopulmonary disease. Admit MS exacerbation.  AMS back to baseline. D-Dimer 440. Started remdesivir and solumedrol (MS). VSS 96% on RA. 5/1/2022-Improving, maintaining o2 on RA. AMS returned to baseline.  5/3/2022- Recieved last dose of remdesivir. VSS Discharged to home.
Arm hurt just for a day; Rash; This is a spontaneous report from a contactable reporter (Patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation.The patient's medical history was not reported. The patient's concomitant medications were not reported. The patient stated that his/her arm hurt just for a day on an unspecified date. Patient got vaccination on Friday around 2 O' clock and his/her arm hurt just for a day and it just went away. Patient broke out of a rash on his/her back, arm and face as well on an unspecified date. Patient did not have any respiratory difficulty or anything. Patient informed he/she did not eat anything different or drink anything, but just wanted to know if the vaccine gave the reaction. Patient had this rash appear tonight, like around 6 o clock and he/she do not know. He/she did not eat anything different or drink anything. But he/she just wanted to know if the vaccine gave the reaction. patient took 50 mg of Benadryl but it seems to disappear. Outcome of the event Arm hurt just for a day was recovered on unspecified date. Outcome of the event rash was recovering.   No follow-up attempts are possible. Information about lot/batch number could not be requested. No further information is expected.
administered vaccine that was in the fridge for too long. Called Pfizer and they said revaccinate patient.
At 1230 heard yell for help. APRN assessed. Mother indicated "eyes rolled back, slumped over and pale. Dr arrived at patint side. PAC brought cold cloth for forehead. Within about 8 minutes patient pink and alert. No complaints.
The patient has a red, swollen, and warm to the touch area. She stated it is in the arm where she had the pneumococcal vaccine (her left arm).  She has been icing it off an on.  She has taken a Benadryl tablet and she stated that has helped with the swelling and redness.  She stated that it was painful around 4 pm.  She called the pharmacy with the complaint of the red swollen and warm to the touch area (below the injection site) around 730 pm the day of vaccination.  I called the patient back around 835 pm to see how she was doing and she stated the Benadryl that she took was helping the redness and it is not sore.  She said the soreness wore off before she called me around 730 pm.
Narrative:  Patient presented to drive up COVID vaccine clinic. He was asked if he wanted a COVID vaccine and a flu shot. Patient said yes and cards were placed on his windshield to indicate he needed both influenza and COVID vaccine booster. Patient arrived to immunization lane with FLU placcard on his windshield after being asked which vaccines he would get. This RN informed patient that I would be giving him a flu shot, to which he agreed. I then asked if he wanted a high dose flu shot, to which he agreed. After administering flu shot to patient he stated that he already had flu shot and did not realize he was getting one. Nursing manager and NP notified. No S/Sx of reaction after vaccination, 15 minute wait period. The exact date and influenza vaccine previously given are unknown as it was not done at our clinic or documented in the patient's medical record. Not aware of any adverse effect at this time. Patient also received COVID Pfizer booster on 11/20/2021.
Inflammation of the arm redness and swelling and warm to touch itchy and painful.No treatment was done was told to wit and see if it persists, after three days the swelling went down and the symptoms subsided, but the arm developed a discolouration with bible patches, no pain but at times it gets itchy.
sore arm; This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to chemicals (sulfites), Allergy to antibiotic, Bladder cancer since 2012, Blood pressure high and Enlarged prostate. Concomitant products included FINASTERIDE (PROSCAR) for BPH, ATENOLOL (TENORMIN) for Blood pressure high, MULTIVITAMIN & MINERAL for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF) for BPH, at an unspecified dose and frequency and ATORVASTATIN CALCIUM (LIPTOR [ATORVASTATIN CALCIUM]) for Cholesterol blood excessive, at an unspecified dose and frequency. On 19-Jan-2021, PAIN IN EXTREMITY (sore arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: other (High) blood pressure is very high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-246742 (Patient Link).
Rash temp of 101; Rash temp of 101; body aches; This is a spontaneous report from a contactable other health professional.   This report involves a 33-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose in the left arm on 09Jan2021 10:45 for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Previously patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown dose for covid-19 immunisation. On 10Jan2021, the patient experienced rash, temp of 101, body aches with outcome of recovering.  The vaccine was administered at Hospital Facility. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient was not pregnant at the time of vaccination.  Information on the Lot/Batch number has been requested.
pain at the injection site; lethargic; tired for a day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the injection site), LETHARGY (lethargic) and FATIGUE (tired for a day) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at the injection site), LETHARGY (lethargic) and FATIGUE (tired for a day). At the time of the report, VACCINATION SITE PAIN (pain at the injection site), LETHARGY (lethargic) and FATIGUE (tired for a day) outcome was unknown.            Concomitant medications include inhalers for COPD.  No treatment medications provided.   This case was linked to MOD-2021-310917, MOD-2021-311064 (Patient Link).
swelling of the left eye; mild numbness and tingling on the left side of the lower lip; numbness and tingling of the throat; numbness and tingling of the throat; mild numbness and tingling on the left side of the lower lip; numbness and tingling of the hand; swelling on the left side of the face; numbness and tingling of the hand; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (swelling of the left eye), PARAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PHARYNGEAL PARAESTHESIA (numbness and tingling of the throat), PHARYNGEAL HYPOAESTHESIA (numbness and tingling of the throat) and HYPOAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was Reported.  Concomitant products included L-lysine                                                       for herpes simplex virus for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced EYE SWELLING (swelling of the left eye), PARAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PHARYNGEAL PARAESTHESIA (numbness and tingling of the throat), PHARYNGEAL HYPOAESTHESIA (numbness and tingling of the throat), HYPOAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PARAESTHESIA (numbness and tingling of the hand), SWELLING FACE (swelling on the left side of the face) and HYPOAESTHESIA (numbness and tingling of the hand). At the time of the report, EYE SWELLING (swelling of the left eye), PARAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PHARYNGEAL PARAESTHESIA (numbness and tingling of the throat), PHARYNGEAL HYPOAESTHESIA (numbness and tingling of the throat), HYPOAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PARAESTHESIA (numbness and tingling of the hand), SWELLING FACE (swelling on the left side of the face) and HYPOAESTHESIA (numbness and tingling of the hand) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   treatment information include Benadryl 50mg around 9pm, and 25 mg at midnight (April 27,2021)
Vaccine administered after 3 days of puncturing the vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 3 days of puncturing the vial) in an 82-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 3 days of puncturing the vial). On 20-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 3 days of puncturing the vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received contains updated event verbatim.
1/14/2021 pain, fatigue, headache and fever- took night off due to reaction subsequently within days, fatigue, lethargy, headache, swollen joints (hips, knees ,left foot) Vaginal bleeding and pain (I'm post Menopausal) total body weakness, stomach pain, . I have gained a lot of weight, chest pains, can't get out of bed many days and I applied for assistance which is under review,
When my Daughter was born she was healthy, awake, and very vibrant. I was too sleepy to realize at the time that they were pulling scare tactics. I told the pediatrician prior to the birth of my child, I didn't want any vaccinations for my child period. I was told they would bring me the waivers to sign and they wouldn't vaccinate my child. They lied!! I only saw proof when I saw rashes on my daughter's thighs. Then my husband pointed out how listless she was compared to when she was born. Then I went back and remembered how my first daughter behaved after birth who was not vaccinated, she was lively, upbeat. But my just born child was injected with poisons and was fighting for her life, and she wasn't even a day old. It made me want to cry. To some parents it's normal for newborn to behave this way, but it is not true!!! I've seen, and I know different.
sore arm began evening of vaccine 9/20, not out of the ordinary. Following morning 9/21 had myalgia, nausea and loose stool. on 9/22 had fever of 101°, rigors, myalgia severe diarrhea, abdominal cramping, fatigue, loss of appetite. Still with diarrhea and abdominal cramping today on 9/23, but energy starting to return, less GI cramping
2AUG93 pt given vax large-hard-lump @ site approx 2 1/2-3" in circumference; very sore, but can move; low grade fever also; seen by MD; area inflammed & hot to touch;  MD felt infected @ site;
Discharge Provider: DO Primary Care Provider at Discharge: MD   Admission Date: 8/16/2022 Discharge Date: 8/20/2022  HOSPITAL COURSE: Patient is a 67-year-old male with history of coronary artery disease, stage IV CKD, oropharyngeal dysphagia with known aspiration, pulmonary aspergillosis, carotid artery disease and Barrett's esophagus with history of throat cancer who presented with increased cough, shortness of breath, increased sputum production and generalized weakness.  He called EMS, and was placed on 4 L of oxygen due to hypoxia.  Upon arrival to the emergency department, he was noted to have oxygen saturation of 87% on room air, and was placed on 2 L. Labs showed a sodium of 132, potassium 2.7, creatinine 2.57, troponin 69 and WBC count 10.6.  CT angiogram showed diffuse central lobular nodular densities in bilateral lower lobes and consolidation in the left lower lobe.  He was noted to have lymphoid tissue in the mediastinum and hilum.  He was tested for COVID-19, which returned positive.  He was given IV potassium, 1 L of fluids, IV Zosyn and Decadron in the emergency department.  He was admitted to the hospitalist service for further management.   Upon admission, he was continued on Decadron for this COVID-19.  SLP was consulted, given his known history of dysphagia and aspiration.  The patient has continually stated that he will continue with oral intake understanding risk of aspiration, and continued to feel this way.  SLP did not feel that further evaluation was necessary, given this history.  Due to worsening left lower lobe infiltrate and worsening lymphadenopathy, pulmonology was consulted.  Patient was history of pulmonary Aspergillosis, and has been treated with voriconazole by infectious disease.  Therefore, ID was also consulted.  They recommended continued treatment with IV Zosyn and patient was restarted on voriconazole for chronic pulmonary Aspergillosis.  Pulmonology felt that bronchoscopy should be done, and was completed on 8/18.  Bronchoscopy did note purulent secretions and 5 EBUS-guided needle aspirates were obtained for further evaluation of his lymphadenopathy.  Pathology is pending.  Cultures have returned with Staph aureus (sensitivity pending), and he will be placed on a 5-day course of Doxycycline at discharge.  He remained minimally symptomatic and afebrile from a COVID standpoint, and was able to be weaned to room air.   He was felt stable for discharge on 8/20/22.  He will be discharged on 5 days of Doxycycline for treatment of Staph aureus pneumonia.  He will need outpatient follow-up of lymph node biopsy results, and should have follow-up CMP and voriconazole level checked in 7-10 days, per ID recommendations.  He should follow-up with Pulmonology in 1 month.  He should follow-up with his PCP in 1 week.
Swelling, redness, warmth and tenderness to Right Leg.  Given Keflex 125mg/5ml 2 times per day for 10 days.
Received 1st dose of Moderna COVID 19 vaccine from expired; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received 1st dose of Moderna COVID 19 vaccine from expired) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.No concomitant medication was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received 1st dose of Moderna COVID 19 vaccine from expired). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received 1st dose of Moderna COVID 19 vaccine from expired) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.     This case was linked to US-MODERNATX, INC.-MOD-2021-097752 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-097752:
Dizzied; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzied) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DIZZINESS (Dizzied). At the time of the report, DIZZINESS (Dizzied) outcome was unknown.            Patient's concomitant medication included blood pressure medication.  No corrective treatment was provided.
Pt developed a severe headache and nausea (she rated pain at 7/10) after administration of the vaccine. Has a history of migraines and reported that this felt similar. Pt had to lay down in a dark room. 500mg acetaminophen was administered and pt reported that the nausea subsided and her headache went down to a 5/10. She stayed a the clinic for about 1 hour and was monitored and then was able to go home.
patient describes facial swelling for several days after vaccine administration, a diffuse rash that has mostly resolved on arms and trunk of body , and persistent joint pain to the shoulders, hips, and knees
9 days after receiving vaccine redness occurred; 9 days after receiving vaccine swelling occurred; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (9 days after receiving vaccine redness occurred) and VACCINATION SITE SWELLING (9 days after receiving vaccine swelling occurred) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 24-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (9 days after receiving vaccine redness occurred) and VACCINATION SITE SWELLING (9 days after receiving vaccine swelling occurred). At the time of the report, VACCINATION SITE ERYTHEMA (9 days after receiving vaccine redness occurred) and VACCINATION SITE SWELLING (9 days after receiving vaccine swelling occurred) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided No treatment information provided
clot in one of the vessels in her brain; severe headaches; Facial pain; This is a spontaneous report from a contactable consumer reporting on behalf of the patient.  A female patient (reporter's sister) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04May2021 (Batch/Lot number was not reported) as 2nd dose, single for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. The patient also received first dose of BNT162B2 on unspecified date (unknown lot number and expiration) for COVID -19 immunization. It was reported that the patient received the second shot of COVID vaccine on 4th of this month (04May2021) and developed severe headaches, facial pain, and other symptoms about a couple of years later. The severity of her headache is so much that they had to get her admitted where medical tests were done in the emergency. CT scan, MRI, ECG, and chest x-rays with unknown results. Everything was done and the doctor is suspecting a clot in one of the vessels in her brain. The reporter further stated, "Can you just guide me about how do I go about it?".  The events resulted in emergency room visit. Outcome of the events was unknown. Information on the lot/batch number has been requested.
Mother phoned in at 04:45 to report red, raised and hardened area on left arm (2" X 2").
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: Patient fainted about 1 minute after vaccination. She was unconcious for 5-10 seconds before recovering. She was given ice water and about 15 minutes later said she felt much better.
Client did not tell nurse that she was pregnant until after she received the intranasal H1N1 vaccine.
COVID Breakthrough case Symptoms began: 08/26/21 Lab confirmed: 09/1/21
pt recvd vax in oct90 using material which was past its expiration date;at time of report no adverse exps noted
About 6 hours after the vaccine was given, the patient started feeling bad. She was shivering and started running a fever of 102 degrees.  She grew weak as hours passed. She also developed a headache. The fever lasted all throughout the night with shivering.  Her body began to hurt. The next day the fever was down in the morning, but her body hurt and had a headache.  Her arm was sore as well at injection site.  That evening, she started running fever again, 101 degrees.  The next day, her body hurt worse, like flu like body aches. This was mostly in the shoulder blades, back of the neck and down her back. The pain is getting worse today in her back.  The site of injection is turning red and feels hard to the touch
Narrative: He relates having developed swelling over the middle part of his upper lip about 3-4 hours after vaccination. This was confirmed by his wife. It began to subside by that evening and was gone the next morning. He did not apply or try any therapies. Mr. Goven denies personal or family history of angioedema. He has unknown non-severe immediate reaction PCN and reported itchiness with acetaminophen/propoxyphene in the past. While experiencing lip swelling, Mr. Goven denied: Pruritus, urticaria, flushing, difficulty breathing, palpitations, confusion/disorientation, dizziness/lightshades, weakness, nausea/vomiting, abdominal cramps and diarrhea. He also denied difficult swelling and does not think anywhere else was swollen. Referred to allergist prior to 2nd dose.
The patient became dizzy and felt as if he might pass out after 15 minutes.  He then was instructed to lay down and elevate his legs.  After 15 more minutes he felt fine and was able to walk out of the store.   Later in the evening he called the pharmacy and told us his arm and tongue were tingling.  He was instructed to seek medical treatment if the symptoms became worse.  We spoke to him later and he stated that his symptoms went away without the use of medications.